Kemadrin

Procyclidine Hydrochloride, the active ingredient in Kemadrin, is an anticholinergic presented as an oral dosage form for oral use. It treats Parkinson's disease and drug‑induced extrapyramidal symptoms in adult patients. GNH USA supplies Kemadrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kemadrin is an anticholinergic drug used to manage movement disorders that involve excessive cholinergic activity. - Parkinson's disease: helps reduce tremor, rigidity and bradykinesia in patients with idiopathic Parkinsonism. - Drug‑induced extrapyramidal symptoms: alleviates dystonia, akathisia and parkinsonian rigidity caused by neuroleptic therapy. - Parkinsonian tremor: improves control of resting tremor associated with Parkinson's disease.

Common Side Effects: - Dry mouth: reduced salivary secretion leading to thirst. - Constipation: slowed gastrointestinal motility. - Blurred vision: accommodation difficulty due to ocular muscle effects. - Dizziness: transient light‑headedness, especially on standing. - Nausea: mild gastrointestinal upset. - Urinary retention: difficulty initiating urination.

Serious or Rare Side Effects: - Confusion or delirium: especially in elderly patients. - Hallucinations: visual or auditory disturbances. - Severe tachycardia: rapid heart rate requiring medical attention. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Neuroleptic malignant syndrome: rare but life‑threatening condition.

Kemadrin should be used with caution in specific patient groups and clinical situations. - Renal impairment: assess kidney function and adjust therapy if needed. - Elderly patients: monitor for increased confusion or falls. - Glaucoma: avoid use in patients with narrow‑angle glaucoma. - Urinary retention: use carefully in individuals with prostate enlargement. - Pregnancy and lactation: safety not established; avoid unless clearly needed. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Procyclidine may interact with several drug classes, requiring attention to avoid adverse outcomes. Major Interactions (Avoid): - Antihistamines: additive anticholinergic effects may cause severe dry mouth and constipation. - Tricyclic antidepressants: increased anticholinergic burden can lead to cardiac arrhythmias. - Antipsychotics: may diminish therapeutic response to antipsychotic treatment. Moderate Interactions (Monitor Closely): - Beta‑blockers: potential for enhanced bradycardia. - Opioids: additive central nervous system depression. - Alcohol: may increase dizziness and sedation.